These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7592024)

  • 21. Bacterial Cell Wall Analogue Peptides Control the Oligomeric States and Activity of the Glycopeptide Antibiotic Eremomycin: Solution NMR and Antimicrobial Studies.
    Izsépi L; Erdei R; Tevyashova AN; Grammatikova NE; Shchekotikhin AE; Herczegh P; Batta G
    Pharmaceuticals (Basel); 2021 Jan; 14(2):. PubMed ID: 33499349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of vancomycin group antibiotics to D-alanine and D-lactate presenting self-assembled monolayers.
    Cooper MA; Fiorini MT; Abell C; Williams DH
    Bioorg Med Chem; 2000 Nov; 8(11):2609-16. PubMed ID: 11092546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A redesigned vancomycin engineered for dual D-Ala-D-ala And D-Ala-D-Lac binding exhibits potent antimicrobial activity against vancomycin-resistant bacteria.
    Xie J; Pierce JG; James RC; Okano A; Boger DL
    J Am Chem Soc; 2011 Sep; 133(35):13946-9. PubMed ID: 21823662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of an inducible vancomycin resistance system in Streptomyces coelicolor reveals a novel gene (vanK) required for drug resistance.
    Hong HJ; Hutchings MI; Neu JM; Wright GD; Paget MS; Buttner MJ
    Mol Microbiol; 2004 May; 52(4):1107-21. PubMed ID: 15130128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular recognition by secondary metabolites.
    Williams DH; Stone MJ; Mortishire-Smith RJ; Hauck PR
    Biochem Pharmacol; 1990 Jul; 40(1):27-34. PubMed ID: 2372307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptidoglycan synthesis and structure in Staphylococcus haemolyticus expressing increasing levels of resistance to glycopeptide antibiotics.
    Billot-Klein D; Gutmann L; Bryant D; Bell D; Van Heijenoort J; Grewal J; Shlaes DM
    J Bacteriol; 1996 Aug; 178(15):4696-703. PubMed ID: 8755902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular modeling of Gram-positive bacteria peptidoglycan layer, selected glycopeptide antibiotics and vancomycin derivatives modified with sugar moieties.
    Ślusarz R; Szulc M; Madaj J
    Carbohydr Res; 2014 May; 389():154-64. PubMed ID: 24685455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-molecule force spectroscopy and imaging of the vancomycin/D-Ala-D-Ala interaction.
    Gilbert Y; Deghorain M; Wang L; Xu B; Pollheimer PD; Gruber HJ; Errington J; Hallet B; Haulot X; Verbelen C; Hols P; Dufrêne YF
    Nano Lett; 2007 Mar; 7(3):796-801. PubMed ID: 17316058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dimerization of A82846B, vancomycin and ristocetin: influence on antibiotic complexation with cell wall model peptides.
    Linsdell H; Toiron C; Bruix M; Rivas G; Menéndez M
    J Antibiot (Tokyo); 1996 Feb; 49(2):181-93. PubMed ID: 8621360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cooperative binding interactions of glycopeptide antibiotics.
    Shiozawa H; Chia BC; Davies NL; Zerella R; Williams DH
    J Am Chem Soc; 2002 Apr; 124(15):3914-9. PubMed ID: 11942828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MM 45289, a potent glycopeptide antibiotic which interacts weakly with diacetyl-L-lysyl-D-alanyl-D-alanine.
    Good VM; Gwynn MN; Knowles DJ
    J Antibiot (Tokyo); 1990 May; 43(5):550-5. PubMed ID: 2113517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deconstructing vancomycin.
    Walsh C
    Science; 1999 Apr; 284(5413):442-3. PubMed ID: 10232990
    [No Abstract]   [Full Text] [Related]  

  • 33. Dimerization and membrane anchors in extracellular targeting of vancomycin group antibiotics.
    Beauregard DA; Williams DH; Gwynn MN; Knowles DJ
    Antimicrob Agents Chemother; 1995 Mar; 39(3):781-5. PubMed ID: 7793894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and evaluation of analogues of the bacterial cell-wall peptidoglycan motif L-Lys-D-Ala-D-Ala for use in a vancomycin biosensor.
    Hernout O; Berthoin K; Delattre I; Tulkens PM; Carryn S; Marchand-Brynaert J
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5758-62. PubMed ID: 17855088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The structure of an asymmetric dimer relevant to the mode of action of the glycopeptide antibiotics.
    Groves P; Searle MS; Mackay JP; Williams DH
    Structure; 1994 Aug; 2(8):747-54. PubMed ID: 7994574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crystal structures of the complexes between vancomycin and cell-wall precursor analogs.
    Nitanai Y; Kikuchi T; Kakoi K; Hanamaki S; Fujisawa I; Aoki K
    J Mol Biol; 2009 Feb; 385(5):1422-32. PubMed ID: 18976660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substrate Inhibition of VanA by d-Alanine Reduces Vancomycin Resistance in a VanX-Dependent Manner.
    van der Aart LT; Lemmens N; van Wamel WJ; van Wezel GP
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4930-9. PubMed ID: 27270282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystal structure of vancomycin.
    Schäfer M; Schneider TR; Sheldrick GM
    Structure; 1996 Dec; 4(12):1509-15. PubMed ID: 8994975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative proteomic analysis of Staphylococcus aureus strains with differences in resistance to the cell wall-targeting antibiotic vancomycin.
    Pieper R; Gatlin-Bunai CL; Mongodin EF; Parmar PP; Huang ST; Clark DJ; Fleischmann RD; Gill SR; Peterson SN
    Proteomics; 2006 Aug; 6(15):4246-58. PubMed ID: 16826566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala.
    Ge M; Chen Z; Onishi HR; Kohler J; Silver LL; Kerns R; Fukuzawa S; Thompson C; Kahne D
    Science; 1999 Apr; 284(5413):507-11. PubMed ID: 10205063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.